3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
12
Carcinoma, Intraductal, Noninfiltrating
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sexual Dysfunctions, Psychological
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
HER2 Negative Breast Cancer
1
Endometrial Neoplasms
1
Carcinoma, Lobular
1
Carcinoma, Ductal, Breast
1
Breast Neoplasms, Male
1
Breast Neoplasm Female
1
Breast Diseases
1
Breast Carcinoma In Situ
1
Anatomic Stage II Breast Cancer AJCC v8
1
Advanced Breast Cancer
1
Interventions
Specimen Handling
6
Magnetic Resonance Spectroscopy
6
Biopsy
6
Doxorubicin
5
pembrolizumab
4
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Cyclophosphamide
4
liposomal doxorubicin
3
fludarabine
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
ensartinib
2
atezolizumab
2
anlotinib
2
Temozolomide
2
Radiation
2
Irinotecan
2
Ifosfamide
2
Carboplatin
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Anastrozole
×
30 days
×
Clear all
No trials found.